Skip to content
NewsBlazeIN – Lifestyle
Author:
Anteris Technologies Global Corp.
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
June 8, 2026
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
May 13, 2026
Anteris Announces Results for the First Quarter of 2026
May 12, 2026
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
May 5, 2026
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
April 28, 2026